Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study
Matthew Law(UNSW Sydney), Wafaa El‐Sadr(Columbia University Irving Medical Center), Rodolphe Thiébaut(Université de Bordeaux), Ole Kirk(University of Copenhagen), Nina Friis‐Møller(University of Copenhagen), Linda Morfeldt(Hvidovre Hospital), Christian Pradier(Université Côte d'Azur), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Caroline Sabin(Primary Health Care), Stéphane De Wit(Université Libre de Bruxelles), Peter Reiss(Amsterdam Institute for Global Health and Development), G. Calvo(Universitat Autònoma de Barcelona)
Cited by 250
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k